Marker HumARA
HumARAWe announce here that our group no longer considers HumARA a suitable DNA marker in forensic casework. BackgroundDesmarais et al. [1] have used HumARA typing as a starting point to generate specialized formulae for ChrX typing in forensic practice. Hence, these markers are well established in forensic DNA typing. However, it has been known from the very beginning of HumARA testing that the HumARA CAG repeat, in contrast to all other forensic DNA markers, is located in a coding region (androgen receptor gene, exon 1). This means the repeat codes for a polyglutamine tract. La Spada et al. [2] proved that X-linked spinal and bulbar muscular atrophy (SBMA) is attributable to a mutation at this locus; the disease occurs when there are trinucleotide repeat lengths of more than 43 bp. Apart from the SBMA disease, HumARA typing can detect a number of further health risks, such as an increased risk of impaired spermatogenesis and increased risks of breast, endometrial, colorectal, and prostate cancer.
References
NoteNo data. |
NewsBased on the review of december 2018, it has been decided in cooperation with the X working group to remove the PI calculation from this website. |
|||||||||||||||||||